Organon Shareholders Approve Merger with Sun Pharma USA

Corporate Action

โดย MarketBeat·Read original

Summary · why it matters

Organon shareholders approved the company's proposed merger with Sun Pharmaceutical Holdings USA at a virtual special meeting, clearing a major step in the deal. Under the agreement, Sun Pharma's merger subsidiary will combine with Organon, with Organon surviving as a wholly owned subsidiary of Sun Pharma USA. Shareholders also gave non-binding advisory approval to possible merger-related compensation for Organon's named executive officers. Final certified voting results will be filed with the SEC in a Form 8-K.

Organon & Co ▲